NCT04276714

Brief Summary

At the early stage of the amputation, the residual limb presents post-surgical fluctuations related to post-operative phase, which would need a frequent prosthetic adjustment. In most cases, the volume of residual limb is constant from 12 to 18 months after surgery. However, some daily fluctuations could appear due to an underlying vascular disease for example, which could be painful and impact the quality of life with a constant need of prosthetics adjustment. The goal of this study is to assess the effectiveness of a system-adjusted fitting in comparison with a standard fitting.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 19, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

February 22, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2021

Completed
Last Updated

July 6, 2022

Status Verified

July 1, 2022

Enrollment Period

16 days

First QC Date

February 7, 2020

Last Update Submit

July 1, 2022

Conditions

Keywords

residual limbspainadjustable socket

Outcome Measures

Primary Outcomes (1)

  • Pain change assessment

    Assess the impact of the Revofit™ system adjusted-fitting on residual limb pain compared to a classic fitting with a daily Visual Analog Scale evaluation \[VAS : 0 to 10 which constitues the worst outcome\].

    four weeks

Secondary Outcomes (4)

  • Everyday comfort

    four weeks

  • Functional effects in twin task

    Once a week during four weeks

  • Functional effects in simple task

    Once a week during four weeks

  • Patient satisfaction with assistive technology

    Once a week during four weeks

Study Arms (2)

Adjustable socket

EXPERIMENTAL

First week of the study is with adjustable socket

Other: Socket without Revofit systemOther: Socket with Revofit system

Classical socket

EXPERIMENTAL

First week of the study is with classical socket

Other: Socket without Revofit systemOther: Socket with Revofit system

Interventions

All the tests are evaluate during one week with the classical type of fittings

Adjustable socketClassical socket

All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)

Adjustable socketClassical socket

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years old and above
  • Above knee or below knee amputation (irrespective of etiology and time from amputation)
  • Residual limb pain
  • Prosthetic with classic fitting
  • Fluctuations of residual limb requiring prosthetic adaptation (stump cotton sock, wedgning fitting …)
  • Recipients or registered with a social security scheme
  • Informed consent form signed beforehand

You may not qualify if:

  • Patient with peripheral neuropathies contraindicating the use of Revofit system
  • Pregnant woman, nursing mother or parturiant
  • Patient in detention by judicial or administrative decision
  • Patient undergoing psychiatric compulsory care
  • Patient in a health or social institution for purposes other than research
  • Legally protected person
  • Patient unable to express their consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

DIMONAIS

Angers, 49100, France

Location

MeSH Terms

Conditions

DiseasePain

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Mickaël Dinomais

    MD University hospital Angers

    PRINCIPAL INVESTIGATOR
  • Yoann RONZI

    MD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Single Case Experimental Design : multiple N of 1 trial
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2020

First Posted

February 19, 2020

Study Start

February 22, 2021

Primary Completion

March 10, 2021

Study Completion

March 10, 2021

Last Updated

July 6, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations